A detailed history of Parsec Financial Management, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Parsec Financial Management, Inc. holds 9,928 shares of REGN stock, worth $7.33 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
9,928
Previous 9,907 0.21%
Holding current value
$7.33 Million
Previous $7.15 Million 14.13%
% of portfolio
0.34%
Previous 0.32%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 06, 2023

BUY
$680.49 - $826.97 $14,290 - $17,366
21 Added 0.21%
9,928 $8.16 Million
Q4 2022

Feb 06, 2023

BUY
$705.89 - $766.39 $292,944 - $318,051
415 Added 4.37%
9,907 $7.15 Million
Q3 2022

Nov 07, 2022

BUY
$573.97 - $724.32 $219,830 - $277,414
383 Added 4.2%
9,492 $6.54 Million
Q2 2022

Jul 06, 2022

BUY
$548.35 - $738.84 $205,631 - $277,065
375 Added 4.29%
9,109 $5.39 Million
Q1 2022

May 09, 2022

BUY
$595.12 - $698.43 $390,398 - $458,170
656 Added 8.12%
8,734 $6.1 Million
Q4 2021

Feb 08, 2022

BUY
$543.48 - $670.97 $138,043 - $170,426
254 Added 3.25%
8,078 $5.1 Million
Q3 2021

Nov 10, 2021

BUY
$574.03 - $680.96 $561,401 - $665,978
978 Added 14.29%
7,824 $4.82 Million
Q2 2021

Jul 26, 2021

BUY
$472.8 - $558.54 $246,801 - $291,557
522 Added 8.25%
6,846 $3.82 Million
Q1 2021

Apr 23, 2021

BUY
$446.73 - $548.2 $354,703 - $435,270
794 Added 14.36%
6,324 $2.99 Million
Q4 2020

Feb 03, 2021

BUY
$478.3 - $607.98 $13,870 - $17,631
29 Added 0.53%
5,530 $2.67 Million
Q3 2020

Nov 06, 2020

SELL
$544.75 - $658.21 $148,716 - $179,691
-273 Reduced 4.73%
5,501 $3.08 Million
Q2 2020

Aug 04, 2020

SELL
$493.32 - $643.92 $267,379 - $349,004
-542 Reduced 8.58%
5,774 $3.6 Million
Q1 2020

May 08, 2020

SELL
$336.18 - $494.43 $408,458 - $600,732
-1,215 Reduced 16.13%
6,316 $3.08 Million
Q4 2019

Jan 29, 2020

SELL
$274.13 - $376.51 $971,790 - $1.33 Million
-3,545 Reduced 32.01%
7,531 $2.83 Million
Q3 2019

Oct 23, 2019

SELL
$273.46 - $318.39 $1.24 Million - $1.44 Million
-4,518 Reduced 28.97%
11,076 $3.07 Million
Q2 2019

Jul 23, 2019

BUY
$299.6 - $414.82 $2.21 Million - $3.06 Million
7,375 Added 89.73%
15,594 $0
Q1 2019

Apr 25, 2019

BUY
$372.08 - $439.57 $2.17 Million - $2.56 Million
5,830 Added 244.04%
8,219 $3.38 Million
Q4 2018

Jan 29, 2019

BUY
$335.82 - $403.04 $802,273 - $962,862
2,389 New
2,389 $892,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Parsec Financial Management, Inc. Portfolio

Follow Parsec Financial Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parsec Financial Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Parsec Financial Management, Inc. with notifications on news.